Updated label touts Victoza's superiority for type 2 diabetes

04/8/2012 | Reuters

Novo Nordisk said the FDA is updating labeling for Victoza to include a clinical finding that the type 2 diabetes medicine is superior to Merck & Co.'s Januvia in terms of glucose control and weight loss. The label also reflects approved use of Victoza in combination with basal insulin.

View Full Article in:


Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Vice President of Regulatory Affairs
Pentec Health
Boothwyn, PA
Sr Coordinator Clinical Research (US/TA/00/0073/SL) - 1400000AQX
Santa Clara, CA
Senior Director, Biostatistics
Edwards Lifesciences
Irvine, CA
Diagnostic Technician
Marlborough, MA
Test Technician
Marlborough, MA